A Phase I Study of Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) in Patients With Advanced Cancers.
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Lenalidomide (Primary) ; Bevacizumab; Fluorouracil; Folinic acid; Oxaliplatin; Sorafenib; Temsirolimus
- Indications Cancer
- Focus Adverse reactions
- 01 Jun 2016 Status changed from active, no longer recruiting to completed.
- 12 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center.
- 14 Mar 2013 Planned number of patients changed from 140 to 180 as reported by ClinicalTrials.gov.